Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
Andres M PinedaJ Kevin HarrisonNeal S KleimanMichael J ReardonJohn V ConteDaniel P O'HairStanley J ChetcutiJian HuangSteven J YakubovJeffrey J PopmaNirat BeoharPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
CoreValve US Pivotal Trial: NCT01240902. CoreValve Continued Access Study: NCT01531374.
Keyphrases
- transcatheter aortic valve implantation
- aortic valve replacement
- chronic kidney disease
- aortic valve
- patients undergoing
- aortic stenosis
- end stage renal disease
- transcatheter aortic valve replacement
- study protocol
- ejection fraction
- clinical trial
- phase iii
- heart failure
- coronary artery disease
- open label
- peritoneal dialysis